Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.

Autor: Epperla, Narendranath1 (AUTHOR) Narendranath.Epperla@osumc.edu, Welkie, Rina Li1 (AUTHOR), Torka, Pallawi2 (AUTHOR), Shouse, Geoffrey3 (AUTHOR), Karmali, Reem4 (AUTHOR), Shea, Lauren5 (AUTHOR), Anampa-Guzmán, Andrea2 (AUTHOR), Oh, Timothy S.4 (AUTHOR), Reaves, Heather6 (AUTHOR), Tavakkoli, Montreh7 (AUTHOR), Lindsey, Kathryn8 (AUTHOR), Greenwell, Irl Brian8 (AUTHOR), Hansinger, Emily9 (AUTHOR), Thomas, Colin9 (AUTHOR), Chowdhury, Sayan Mullick1 (AUTHOR), Annunzio, Kaitlin1 (AUTHOR), Christian, Beth1 (AUTHOR), Barta, Stefan K.7 (AUTHOR), Geethakumari, Praveen Ramakrishnan6 (AUTHOR), Bartlett, Nancy L.5 (AUTHOR)
Zdroj: Journal of Hematology & Oncology. 5/8/2023, Vol. 16 Issue 1, p1-6. 6p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje